We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Diabetes

Journal Scan / Research · October 27, 2021

Glycemic Control With Liraglutide vs Oral Antidiabetic Drugs in Patients With Type 2 Diabetes Uncontrolled on Metformin

Diabetes, Obesity & Metabolism


Additional Info

Diabetes, Obesity & Metabolism
Maintenance of glycaemic control with liraglutide versus oral antidiabetic drugs as add-on therapies in patients with type 2 diabetes uncontrolled with metformin alone: A randomized clinical trial in primary care (LIRA-PRIME)
Diabetes Obes Metab 2021 Oct 07;[EPub Ahead of Print], J Unger, DC Allison, M Kaltoft, K Lakkole, JK Panda, C Ramesh, M Sargin, E Smolyarchuk, M Twine, B Wolthers, G Yarimbas, M Zoghbi

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading